Prosegur Cia de Seguridad SA

Headquarters: Grafelfing, Germany

Employees: 67

CEO: Ms. Natalie Weigand

Market Cap

€317.1 Million

EUR as of Jan. 1, 2023

US$338.0 Million

history Market Cap History

Prosegur Cia de Seguridad SA market capitalization over time

Evolution of Prosegur Cia de Seguridad SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Prosegur Cia de Seguridad SA

Detailed Description

PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gräfelfing, Germany.

Stocks & Indices

Prosegur Cia de Seguridad SA has the following listings and related stock indices.

Stock: FSX: PSG

Stock: XETR: PSG

Stock: BME: PSG



Lochhamer Schlag 21

Grafelfing, 82166


Phone: 89 85 89 639 150

Fax: 89 85 89 639 201